CYTOKINETICS, INCORPORATED (CYTK) Operating margin 2016–2025
CYTOKINETICS, INCORPORATED (CYTK) operating margin by fiscal year — reported operating income divided by reported revenue.
-695.4%FY2025 · since FY2016: 17.6% → -695.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -695.4% | +2207.3 pp |
| FY2024 | -2902.7% | +3687.0 pp |
| FY2023 | -6589.7% | -6247.0 pp |
| FY2022 | -342.8% | -78.2 pp |
| FY2021 | -264.5% | -96.3 pp |
| FY2020 | -168.3% | +199.7 pp |
| FY2019 | -368.0% | -85.7 pp |
| FY2018 | -282.3% | +566.0 pp |
| FY2017 | -848.3% | -865.8 pp |
| FY2016 | 17.6% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More CYTK financial trends
CYTK RevenueCYTK Net incomeCYTK Net marginCYTK Gross profitCYTK Gross marginCYTK Operating incomeCYTK Operating cash flowCYTK Free cash flowCYTK Capital expendituresCYTK Return on equityCYTK Stock buybacksCYTK Dividends paidCYTK Total assetsCYTK Total liabilitiesCYTK Shareholders’ equityCYTK overview →